3,963 results match your criteria: "Doherty Institute for Infection and Immunity[Affiliation]"

Acinetobacter baumannii causes life-threatening infections that are becoming difficult to treat due to increasing rates of multi-drug resistance (MDR) among clinical isolates. This has led the World Health Organization and the CDC to categorize MDR A. baumannii as a top priority for the research and development of new antibiotics.

View Article and Find Full Text PDF
Article Synopsis
  • Salmonella enterica serovar Panama is a significant cause of invasive non-typhoidal salmonellosis in Australia, despite being understudied, with a high incidence rate linked to international travel.
  • A study analyzed genomic epidemiology and antimicrobial resistance in S. Panama isolates in Victoria from 2000 to 2021, finding that over half exhibited multi-drug resistance, and colistin resistance was identified in one isolate.
  • The research also explored the growth dynamics of S. Panama in macrophages, revealing its ability to replicate more effectively compared to S. enterica serovar Typhimurium, although no specific genotype was linked to this enhanced replication.
View Article and Find Full Text PDF

Unconventional T cells, including mucosal-associated invariant T (MAIT), natural killer T (NKT), and gamma-delta T (γδT) cells, comprise distinct T-bet+, IFN-γ+ and RORγt+, IL-17+ subsets which play differential roles in health and disease. NKT1 cells are susceptible to ARTC2-mediated P2X7 receptor (P2RX7) activation, but the effects on other unconventional T-cell types are unknown. Here, we show that MAIT, γδT, and NKT cells express P2RX7 and are sensitive to P2RX7-mediated cell death.

View Article and Find Full Text PDF

Summary: DamID sequencing is a technique to map the genome-wide interaction of a protein with DNA. Damsel is the first Bioconductor package to provide an end to end analysis for DamID sequencing data within R. Damsel performs quantification and testing of significant binding sites along with exploratory and visual analysis.

View Article and Find Full Text PDF

Improved tracking of corneal immune cell dynamics using confocal microscopy.

Biomed Opt Express

November 2024

Department of Optometry and Vision Sciences, The University of Melbourne, Melbourne 3010, Australia.

confocal microscopy (IVCM) is a widely used technique for imaging the cornea of the eye with a confocal scanning light ophthalmoscope. Cellular resolution and high contrast are achieved without invasive procedures, suiting the study of living humans. However, acquiring useful image data can be challenging due to the incessant motion of the eye, such that images are typically limited by noise and a restricted field of view.

View Article and Find Full Text PDF

Background: Prompt antibiotic administration for febrile neutropenia (FN) is standard of care, and targets of time to antibiotics (TTA) <60 min are common. We sought to determine the effect of TTA ≥60 versus <60 min on adverse outcomes (intensive care unit (ICU) admission or death) in children with cancer and FN. Effect modification by a decision rule that predicts infection (AUS-rule) and bacteraemia were also investigated.

View Article and Find Full Text PDF
Article Synopsis
  • Cytomegalovirus (CMV) can lead to serious health issues in immunocompromised patients, making it crucial to monitor CMV levels and assess treatments effectively.
  • This study compared the accuracy and reliability of three commercial CMV quantitative assays across different platforms, testing 136 clinical plasma samples.
  • Results showed all assays were precise and provided similar results, with the best agreement between the Aptima and Alinity m assays, indicating their effectiveness for monitoring CMV levels in patients.
View Article and Find Full Text PDF

The Platform Trial In COVID-19 priming and BOOsting (PICOBOO): The immunogenicity, reactogenicity, and safety of licensed COVID-19 vaccinations administered as a second booster in BNT162b2 primed individuals aged 18-<50 and 50-<70 years old.

J Infect

December 2024

Wesfarmers Centre of Vaccines and Infectious Diseases, The Kids Research Institute of Australia, Nedlands, Australia; Centre for Child Health Research, University of Western Australia, Crawley, Australia; Centre for Child Health Research, University of Western Australia, Crawley, Australia; General Paediatrics and Immunology Departments, Perth Children's Hospital, Nedlands, Australia.

Objectives: PICOBOO is a randomised, adaptive trial evaluating the immunogenicity, reactogenicity, and safety of COVID-19 booster strategies. Here, we present data for second boosters among individuals aged 18-<50 and 50-<70 years old primed with BNT162b2 until Day (D) 84.

Methods: Immunocompetent adults who had received two doses of BNT162b2 and any licensed COVID-19 booster at least three months prior were eligible.

View Article and Find Full Text PDF

Superantigens (sAgs) are bacterial virulence factors that induce a state of immune hyperactivation by forming a bridge between certain subsets of T cell receptor (TCR) β chains on T lymphocytes, and class II major histocompatibility complex (MHC-II) molecules; this cross-linking leads to indiscriminate T cell activation, cytokine storm and toxic shock. Here we show that sAg exposure drives the preferential expansion of naive and central memory T cell subsets, but not effector or resident memory T cells, which instead, hyper release pro-inflammatory cytokines. A targeted therapeutic approach to minimise cytokine release by effector memory T cells attenuated sAg-induced cytokine release.

View Article and Find Full Text PDF

Optimising detection of thrombosis in paediatric Staphylococcus aureus bacteraemia: A prospective interventional sub-study protocol.

Infect Dis Now

November 2024

Wesfarmers Centre of Vaccines and Infectious Disease, The Kids Research Institute Australia, Perth, Australia; School of Medicine, University of Western Australia, Perth, Australia; Perth Children's Hospital, Perth, Australia.

Introduction: Staphylococcus aureus bacteraemia (SAB) is the most common cause of sepsis, contributing to paediatric intensive care unit admission in Australia and New Zealand. While deep venous thrombosis (DVT) has been reported in children with invasive S. aureus infections, the actual frequency and possible effects of thrombosis on disease severity and outcome in paediatric SAB remain unknown.

View Article and Find Full Text PDF
Article Synopsis
  • PreHevbrio® is a 3-antigen hepatitis B virus (HBV) vaccine designed to produce three types of HBV envelope proteins, leading to a more robust immune response compared to traditional single-antigen vaccines.
  • The study found that the increased immunogenicity of the 3-antigen vaccine is not linked to glycosylation, but rather to its ability to trigger T cell responses specific to the PreS antigens.
  • Results show that the 3-antigen vaccine generates stronger and longer-lasting antibody responses, correlating significantly with T cell activity and better antibody production.
View Article and Find Full Text PDF

Unlabelled: uses over 300 translocated effector proteins to rewire host cells during infection and create a replicative niche for intracellular growth. To date, several studies have identified effectors that indirectly and directly regulate the activity of other effectors, providing an additional layer of regulatory complexity. Among these are "metaeffectors," a special class of effectors that regulate the activity of other effectors once inside the host.

View Article and Find Full Text PDF
Article Synopsis
  • Diabetes mellitus increases the risk of severe respiratory diseases like influenza and COVID-19, primarily due to glycemic variability rather than average blood glucose levels.
  • A study used blood samples and continuous glucose monitoring from individuals with type 1 diabetes to examine how glycemic variability affects T cell responses to influenza.
  • Higher glycemic variability was linked to a decreased proportion of specific T cells responding to the influenza virus, indicating the importance of monitoring glycemic variability for understanding immune responses in diabetic individuals.
View Article and Find Full Text PDF

Recovery of culturable Streptococcus pyogenes from swabs stored at different temperatures.

Environ Microbiol Rep

December 2024

Wesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Nedlands, Western Australia, Australia.

Improving our understanding of superficial Streptococcus pyogenes (Strep A) carriage and transmission necessitates robust sampling methods. Here, we compared the effect of storing swab samples in fridge (+4°C) and freezer (-20°C) conditions on the recovery of laboratory-cultured S. pyogenes.

View Article and Find Full Text PDF

Examining the Utility of Penicillin Allergy Clinical Decision Rules: How Low Will You Go?

J Allergy Clin Immunol Pract

November 2024

Centre for Antibiotic Allergy and Research, Department of Infectious Diseases and Immunology, Austin Health, Heidelberg, Victoria, Australia; Department of Infectious Diseases, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Parkville, Victoria, Australia.

View Article and Find Full Text PDF

High incidence of multidrug-resistant tuberculosis in Bhutan: A cohort study based on national TB surveillance data.

IJID Reg

December 2024

Department of Microbiology and Immunology at The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia.

Objectives: The emergence of multidrug-resistant tuberculosis (MDR-TB) has made the elimination of TB difficult. Currently, there are limited data on MDR-TB and other drug-resistant TB in Bhutan. We aimed to estimate the incidence and explore the potential risk factors associated with MDR/pre-extensively drug-resistant (pre-XDR)-TB using comprehensive national TB data.

View Article and Find Full Text PDF

This untargeted metabolomics study investigated the synergistic antibacterial activity of polymyxin B and Leu-teixobactin, a depsipeptide inhibitor of cell wall biosynthesis. Checkerboard microdilution assays revealed a significant synergy against polymyxin-susceptible and -resistant A. baumannii, excluding lipopolysaccharide-deficient variants.

View Article and Find Full Text PDF

Identifying factors that influence the use of pathogen genomics in Australia and New Zealand: a protocol.

Front Public Health

November 2024

Evaluation and Implementation Science Unit, Centre for Health Policy, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia.

Article Synopsis
  • The study focuses on understanding how pathogen genomics, specifically whole genome sequencing, is utilized in public health for infectious disease management in Australia and New Zealand.
  • Researchers plan to use qualitative comparative analysis (QCA) to compare cases of pathogen genomics application and develop a rubric to pinpoint influential factors affecting its use.
  • The results will be drawn from a combination of document reviews and interviews with health technicians, aiming to uncover pathways that enhance the effectiveness of pathogen genomics in public health responses.
View Article and Find Full Text PDF
Article Synopsis
  • The study analyzed central line-associated bloodstream infections (CLABSI) in adult ICUs in Victoria, Australia, over 11 years, focusing on incidence rates, pathogens, and antimicrobial resistance.
  • A total of 608 CLABSI events were reported, showing a significant decline in incidence from 1.39 to 0.70 per 1,000 central-line days, while the most common pathogen identified was coagulase-negative Staphylococci, with a 69.0% increase in infections caused by this organism.
  • Despite the overall decrease in CLABSI, the study noted a stable trend in antimicrobial resistance rates, with a decrease in MRSA and increases in vancomycin and ceftriaxone-resistant pathogens,
View Article and Find Full Text PDF

Assessing the effect of model specification and prior sensitivity on Bayesian tests of temporal signal.

PLoS Comput Biol

November 2024

Peter Doherty Institute for Infection and Immunity, Department of Microbiology and Immunology, University of Melbourne, Melbourne, Australia.

Article Synopsis
  • Molecular clocks have transformed our understanding of microbe evolution by allowing researchers to use molecular sequences to estimate evolutionary rates and timelines, but require calibration data from various time points for accuracy.
  • A new Bayesian method, BETS (Bayesian Evaluation of Temporal Signal), offers improvements over older techniques by examining how different phylogenetic models influence the detection of temporal signals in evolutionary data.
  • Researchers recommend using prior predictive simulations, conducting sensitivity analyses on prior choices, and selecting an appropriate molecular clock model to enhance the reliability of molecular clock estimates.
View Article and Find Full Text PDF
Article Synopsis
  • Buruli ulcer (BU) is a neglected tropical disease caused by the bacterium Mycobacterium ulcerans, primarily affecting skin and subcutaneous tissue, with transmission dynamics varying by geographic area, particularly in endemic regions like Victoria, Australia.
  • In a study conducted in Melbourne and Geelong, researchers conducted necropsies and surveillance on possums, revealing that 77% of the 26 examined possums were common ringtails, with 9 showing cutaneous ulcers and 73% testing positive for M. ulcerans DNA, indicating a significant reservoir in these animals.
  • The findings suggest that possums may contract BU through bites from infected mosquitoes, environmental sources, or wounds, highlighting the need for a One Health approach to
View Article and Find Full Text PDF

Controlled human infection models (CHIMs) are a critical tool for the understanding of infectious disease progression, characterising immune responses to infection and rapid assessment of vaccines or drug treatments. There is increasing interest in using CHIMs for vaccine development and an obvious need for widely available and fit-for-purpose challenge agents. Inno4Vac is a large European consortium working towards accelerating and de-risking the development of new vaccines, including the development of CHIMs for influenza, respiratory syncytial virus and Clostridioides difficile.

View Article and Find Full Text PDF